×
-0.0153846153846154 -0.0717948717948717 -0.0256410256410256 0.0769230769230769 0.282051282051282 0.194871794871795 0.174358974358974 0.158974358974359
Stockreport

DBV Technologies peanut allergy drug fails key study [Reuters]

DBV Technologies SA American (DBVT)  More Company Research Source: Reuters
US:NASDAQ Investor Relations: dbv-technologies.com/en/investor-relations
PDF DBV Technologies peanut allergy drug fails key study | Reuters 2 Min Read Oct 20 (Reuters) - Drug developer DBV Technologies SA said on Friday its peanut allergy treatment did not meet the main goal in a highly anticipated late-stage study. The trial, which tested a 250 microgram stick-on patch called Viaskin Peanut, in 356 children between the ages of 4-11, missed the main goal of achieving a certain tolerance to peanut protein. ( bit.ly/2xbQD5H ) Preliminary results show 12 months of the treatment resulted in 35.3 percent of patients achieving a certain tolerance, versus a higher-than-expected 13.6 percent response from a placebo group. However, DBV said the results showed a statistically significant response with a favorable tolerability profile. Plans to submit a marketing application for the patch to the U.S. Food and Drug Administration (FDA) next year remain unchanged, the French drug developer said. There are currently no U.S. regulator-approved treatments for peanut allergies [Read more]

IMPACT SNAPSHOT EVENT TIME: DBVT
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
DBVT alerts
from News Quantified
Opt-in for
DBVT alerts

from News Quantified
Opt-in for
DBVT alerts

from News Quantified